Antitumor agent-119

Name: Antitumor agent-119
Brand: MedChemExpress
SKU: HY-156775
Rating: 4.5 (1 reviews)

Cat. No.: HY-156775 Purity: 98.03%: FAQs
Data Sheet
SDS

COA
Handling Instructions Technical Support

Antitumor agent-119 (compound 13K) is a 2-benzoxazolyl hydrazone derivative with anticancer activities. Antitumor agent-119 inhibits the cell growth of Butkitt, CCRF-CEM, HeLa, and HT-29 with IC₅₀ values of 30 nM, 140 nM, 100 nM, and 40 nM, respectively.

For research use only. We do not sell to patients.

Antitumor agent-119 Chemical Structure

CAS No. : 913169-79-6

Size	Stock	Quantity
1 mg	In-stock	Estimated Time of Arrival: December 31
5 mg	In-stock	Estimated Time of Arrival: December 31
10 mg	Get quote
50 mg	Get quote

or Bulk Inquiry

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 1 publication(s) in Google Scholar

Featured Recommendations

•Related Screening Libraries:

•Related Small Molecules:

•Related Proteins:

Biological Activity
Purity & Documentation
References
Customer Review

Description

Cellular Effect

Cell Line	Type	Value	Description	References
Burkitts lymphoma cell	IC₅₀	0.03 μM Compound: E-13k, NSC-693638	Antiproliferative activity against Burkitt cells by MTT assay Antiproliferative activity against Burkitt cells by MTT assay	[PMID: 17034140]
CCRF-CEM	IC₅₀	0.14 μM Compound: E-13k, NSC-693638	Antiproliferative activity against CCRF-CEM cells by MTT assay Antiproliferative activity against CCRF-CEM cells by MTT assay	[PMID: 17034140]
HeLa	IC₅₀	0.1 μM Compound: E-13k, NSC-693638	Antiproliferative activity against HeLa cells by SRB assay Antiproliferative activity against HeLa cells by SRB assay	[PMID: 17034140]
HT-29	IC₅₀	0.04 μM Compound: E-13k, NSC-693638	Antiproliferative activity against HT29 cells by SRB assay Antiproliferative activity against HT29 cells by SRB assay	[PMID: 17034140]

Molecular Weight

302.33

Formula

C₁₈H₁₄N₄O

CAS No.

913169-79-6

Appearance

Solid

Color

Off-white to yellow

SMILES

C/C(C1=CC2=C(C=CC=C2)C=N1)=N\NC3=NC4=CC=CC=C4O3

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

Powder	-20°C	3 years
	4°C	2 years
In solvent	-80°C	6 months
	-20°C	1 month

Solvent & Solubility

In Vitro:

DMSO : 100 mg/mL (330.76 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

Preparing
Stock Solutions

Concentration Solvent Mass	1 mg	5 mg	10 mg

1 mM	3.3076 mL	16.5382 mL	33.0764 mL
5 mM	0.6615 mL	3.3076 mL	6.6153 mL
10 mM	0.3308 mL	1.6538 mL	3.3076 mL

View the Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

Molarity Calculator
Dilution Calculator

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

This equation is commonly abbreviated as: C₁V₁ = C₂V₂

Concentration _(start)

Volume _(start)

Concentration _(final)

Volume _(final)

In Vivo:

Select the appropriate dissolution method based on your experimental animal and administration route.

For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for in vivo experiments, it is recommended to prepare freshly and use it on the same day.
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

Protocol 1

Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: ≥ 2.5 mg/mL (8.27 mM); Clear solution

This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.

In Vivo Dissolution Calculator

Please enter the basic information of animal experiments:

Dosage

mg/kg

Animal weight
(per animal)

Dosing volume
(per animal)

μL

Number of animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.

Please enter your animal formula composition:

DMSO +

Tween-80 +

Saline

Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.

The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).

Calculation results:

Working solution concentration: mg/mL

Method for preparing stock solution: mg drug dissolved in μL DMSO (Stock solution concentration: mg/mL).

The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only. If necessary, please contact MedChemExpress (MCE).

Method for preparing in vivo working solution for animal experiments: Take μL DMSO stock solution, add μL . μL , mix evenly, next add μL Tween 80, mix evenly, then add μL Saline.

If the continuous dosing period exceeds half a month, please choose this protocol carefully.

Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.

Purity & Documentation

Purity: 98.03%

Select Batch:

Data Sheet (271 KB) SDS (393 KB)

COA (248 KB) HNMR (128 KB) RP-HPLC (161 KB) LCMS (197 KB)

Handling Instructions (2659 KB)

References

[1]. N. S. Hari Narayana Moorthy, et al. QSAR analysis of 2-benzoxazolyl hydrazone derivatives for anticancer activity and its possible target prediction. Med Chem Res 21, 133–144 (2012).

Complete Stock Solution Preparation Table

Optional Solvent	Concentration Solvent Mass	1 mg	5 mg	10 mg	25 mg

DMSO	1 mM	3.3076 mL	16.5382 mL	33.0764 mL	82.6911 mL
	5 mM	0.6615 mL	3.3076 mL	6.6153 mL	16.5382 mL
	10 mM	0.3308 mL	1.6538 mL	3.3076 mL	8.2691 mL
	15 mM	0.2205 mL	1.1025 mL	2.2051 mL	5.5127 mL
	20 mM	0.1654 mL	0.8269 mL	1.6538 mL	4.1346 mL
	25 mM	0.1323 mL	0.6615 mL	1.3231 mL	3.3076 mL
	30 mM	0.1103 mL	0.5513 mL	1.1025 mL	2.7564 mL
	40 mM	0.0827 mL	0.4135 mL	0.8269 mL	2.0673 mL
	50 mM	0.0662 mL	0.3308 mL	0.6615 mL	1.6538 mL
	60 mM	0.0551 mL	0.2756 mL	0.5513 mL	1.3782 mL
	80 mM	0.0413 mL	0.2067 mL	0.4135 mL	1.0336 mL
	100 mM	0.0331 mL	0.1654 mL	0.3308 mL	0.8269 mL